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Abstract Vitamin K-related analogs induce growth inhibition
via a cell cycle arrest through cdc25A phosphatase inhibition in
various cancer cell lines. We report that 2,3-dichloro-5,8-dihy-
droxy-1,4-naphthoquinone (DDN), a naphthoquinone analog, in-
duces mitochondria-dependent apoptosis in human promyelo-
cytic leukemia HL-60 cells. DDN induced cytochrome c
release, Bax translocation, cleavage of Bid and Bad, and acti-
vation of caspase-3, -8, -9 upon the induction of apoptosis.
Cleavage of Bid, the caspase-8 substrate, was inhibited by the
broad caspase inhibitor z-Val-Ala-Asp(OMe)-£uoromethylke-
tone (zVAD-fmk), whereas cytochrome c release was not af-
fected, suggesting that activation of caspase-8 and subsequent
Bid cleavage occur downstream of cytochrome c release. DDN
inhibited the activation of Akt detected by decreasing level of
phosphorylation. Overexpression of constitutively active Akt
protected cells from DDN-induced apoptosis, while dominant
negative Akt moderately enhanced cell death. Furthermore,
Akt prevented release of cytochrome c and cleavage of Bad in
DDN-treated HL-60 cells. Taken together, DDN-induced apo-
ptosis is associated with mitochondrial signaling which involves
cytochrome c release via a mechanism inhibited by Akt.
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1. Introduction
Menadione (vitamin K3) is a synthetic compound among
the vitamin K family of molecules. Menadione has increas-
ingly been of interest because it is shown to exhibit a broad
range of antitumor activity in human cells and imposed lower
level of toxicity than other cancer chemotherapeutic drugs of
quinone structure, such as doxorubicin, daunorubicin, and
mitomycin C [1^4]. It has been reported that menadione in-
duces growth arrest and apoptosis in various cancer cell lines.
In human hepatoma cells, menadione has an inhibitory e¡ect
on the activity of cdc25 phosphatase, which is involved in cell
cycle regulation through dephosphorylating cyclin-dependent
kinases (CDK) [2]. A thioether analog of menadione that in-
hibits cell growth exerts its e¡ects via sulfhydryl arylation of
cellular protein tyrosine phosphatase [3,4]. In addition, mena-
dione induces G1 arrest by generating superoxide in several
cell lines [3]. Despite a broad range e¡ect of menadione on
growth suppression of cancer cells, its hydrophobicity presents
di⁄culties for use as an anticancer drug. Recently, 2,3-di-
chloro-5,8-dihydroxy-1,4-naphthoquinone (DDN), a new
naphthoquinone analog with polar groups has been described
as the potent growth inhibitor and apoptotic inducer [5]. Pre-
vious studies have shown that DDN induces G1 arrest
through cdc25A phosphatase inhibition, and induces growth
inhibition more potently than other analogs and natural vita-
min K3, without producing ROS in hepatocarcinoma cells [5].
Recently, we have shown that DDN induces cell death in
HeLa cells via an apoptotic pathway by inhibiting transcrip-
tional activity of NF-UB [6]. However, the signal transduction
in DDN-induced apoptosis has not been well established.
Apoptosis is an important regulatory mechanism that elim-
inates unwanted cells during the development and mainte-
nance of cell homeostasis. The regulation of mitochondrial
membrane integrity and the release of cytochrome c from
mitochondria are important processes during apoptosis, and
the Bcl-2 family proteins serve as critical regulators of mito-
chondria-dependent apoptotic pathways [7,8]. For instance,
Bax is a proapoptotic member of the Bcl-2 family that resides
in the cytosol and translocates to mitochondria upon induc-
tion of apoptosis. Bax induces cytochrome c release and cas-
pase activation in vivo and in vitro. In contrast, antiapoptotic
Bcl-2 and Bcl-xL proteins prevent the release of cytochrome c
in the presence of apoptotic stimuli and promote cell survival
[9^11]. In many cases, caspases are activated during apoptosis
through mitochondria-dependent pathways and sequential ac-
tivation of these caspases cleaves various cellular substrates
[12,13]. In addition, a balance between survival and death
signal transduction pathways is important in controlling apo-
ptosis. For apoptosis to e¡ectively occur, survival pathways
must be inhibited or fail to be activated. In this regard, inhi-
bition of the key antiapoptotic kinase Akt is important for
inducing apoptosis by decreasing antiapoptotic signaling in
cells [14^17].
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In this report, we examined signaling pathways during
naphthoquinone analog-induced apoptosis in HL-60 cells,
with particular focus on mitochondria-dependent cell death.
DDN induces apoptosis through activating caspases and al-
terations in subcellular redistribution of Bax and cytochrome
c. In addition, a constitutively active form of Akt inhibits
DDN-induced apoptosis and cytochrome c release. Our data
show that DDN induces apoptosis by regulating multiple sig-
naling pathways that involve decreasing antiapoptotic signals
in addition to increasing proapoptotic signals.
2. Materials and methods
2.1. Materials
DDN was purchased from Sigma-Aldrich. Lipofectamine was ob-
tained from Life Technologies. Fetal bovine serum was from Gibco
BRL, enhanced chemiluminescence (ECL) kit from Amersham Phar-
macia, caspase-3, -8, -9 substrates from Biomol, and Hoechst 33258
from Molecular Probes, Inc. Antibody to cytochrome c was from
Pharmingen. Antibodies to Bax, Bid, Bad, Akt, pAkt (Ser473) and
horseradish peroxidase (HRP)-conjugated secondary antibody were
from Santa Cruz Biotechnology, Inc. z-Val-Ala-Asp(OMe)-£uorome-
thylketone (zVAD-fmk) was from Enzyme System Products.
2.2. Cell viability and internucleosomal DNA fragmentation
HL-60 cells were washed with serum-free RPMI. DDN, zVAD-fmk
or vehicle was diluted into serum-free RPMI at the indicated concen-
trations. Cell viability was determined by the trypan blue exclusion
method at di¡erent time points. For DDN-induced apoptosis, HL-60
cells were maintained in serum-free RPMI for 2 h before experiments.
To analyze apoptosis, HL-60 cells were treated with DDN (1 WM) for
24 h and resuspended in bu¡er containing 1 Wg/ml annexin-£uorescein
isothiocyanate (FITC) as described by the manufacturer’s protocol
(Zymed, South San Francisco, CA, USA). After a 10-min incubation,
the cells were washed, stained with 1 Wg/ml propidium iodide, and
then mounted on a slide. In ¢ve separate ¢elds, both the total number
of cells and the number of annexin-positive cells were counted. DNA
fragmentation and staining nuclei with Hoechst 33258 were performed
as described previously [17]. Apoptosis was also measured using an
enzyme-linked immunosorbent assay (ELISA) based on detection of
histone-associated DNA fragments in the cytoplasm of apoptotic cells
according to the manufacturer’s instructions (Roche, Castle Hill, Aus-
tralia).
2.3. Subcellular fractionation
The basic methodology for the preparation of mitochondria and
cytosol fractions was modi¢ed from a previous report [18]. Brie£y,
HL-60 cells (3U106) at the end of the treatment were harvested and
washed with ice-cold phosphate-bu¡ered saline (PBS). Cells were re-
suspended in 500 Wl of bu¡er A (20 mM HEPES^KOH, pH 7.5, 10
mM KCl, 1.5 mM MgCl2, 1 mM sodium ethylenediamine tetraacetic
acid (EDTA), 1 mM sodium ethyleneglycol-bis-(L-aminoethylether)-
N,N,NP,NP-tetraacetic acid (EGTA), 1 mM dithiothreitol) containing
250 mM sucrose and a mixture of protease inhibitors (1 mM phenyl-
methylsulfonyl £uoride (PMSF), 1% aprotinin, 1 mM leupeptin, 1 Wg/
ml chymostatin). To lyse the cells, the cell suspension was passed ¢ve
times through a 26-gauge needle ¢tted to a syringe. Unbroken cells,
large plasma membrane pieces, and nuclei were removed by centrifug-
ing the homogenates at 1000Ug at 4‡C for 10 min. The resulting
supernatant was subjected to 10 000Ug centrifugation at 4‡C for 20
min. The pellet fraction (i.e. mitochondria) was ¢rst washed with the
above bu¡er A containing sucrose and then solubilized in 50 Wl of
TNC bu¡er (10 mM Tris^acetate, pH 8.0, 0.5% NP-40, 5 mM CaCl2).
The supernatant was recentrifuged at 100 000Ug (4‡C, 1 h) to gener-
ate cytosol.
2.4. Western blot analysis
Cells were solubilized with ice-cold lysis bu¡er containing 1% Tri-
ton X-100, 50 mM NaCl, 25 mM HEPES (pH 7.4), 1 mM EDTA,
1 mM EGTA, 1 mM PMSF, and 10 Wg/ml leupeptin. Insoluble
materials were removed by centrifugation at 10 000Ug for 10 min.
Extracted proteins (50 Wg/well) were separated by sodium dodecyl
sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) on poly-
acrylamide gels, and were electrophoretically transferred onto Immo-
bilon-P membrane. Blocking was performed in Tris-bu¡ered saline
containing 5% skimmed milk powder and 0.1% Tween-20. The mem-
branes were probed with antibodies against caspases, cytochrome c,
Bid, Bax, Bad, Akt or phospho-Akt. Detection was performed with
ECL system. Protein content was determined with Bradford method
using bovine serum albumin as a standard.
2.5. Measurement of caspase activity
Cell lysates were incubated with the colorimetric substrates, N-ace-
tyl-Asp-Glu-Val-Asp-p-nitroanilide (DEVD-pNA) (caspase-3) or N-
acetyl-Ile-Glu-Thr-Asp-p-nitroanilide (IETD-pNA) (caspase-8) or
Ac-N-acetyl-Leu-Glu-His-Asp-p-nitroanilide (Ac-LEHD-pNA) (cas-
pase-9), to measure caspase activity according to the protocol sug-
gested by the manufacturer. Reactions were assembled in microtiter
plate wells by adding 160 Wl of bu¡er B (100 mM HEPES (pH 7.5),
20% (v/v) glycerol, 5 mM dithiothreitol (DTT), and 0.5 mM EDTA)
containing 100 WM substrate to wells containing 50 Wg of cytosolic
protein in 40 Wl of bu¡er A. Plates were incubated at 37‡C for 1 h.
Release of free pNA, which absorbs at 405 nm, was monitored con-
tinuously.
2.6. Transient transfection
Cells were transfected with pECE-MyrAkt or pCMV6-Akt-K179M
[19] using lipofectamine reagent according to the manufacturer’s pro-
tocol. Brie£y, HL-60 cells were incubated in opti-MEM media along
with 1 Wg of plasmid DNA and lipofectamine (10 Wl) for 4 h at 37‡C.
After transfection, cultures were maintained in serum-depleted me-
dium for 15^17 h prior to DDN treatment.
3. Results
3.1. Naphthoquinone analog induces apoptosis in HL-60 cells
To test the cell death e¡ect of DDN, HL-60 cells were
treated with di¡erent concentrations of DDN for 24 h, and
cell viability was examined with trypan blue dye exclusion. As
shown in Fig. 1A, DDN induced cell death in a dose-depen-
dent manner, with a concentration of 1 WM DDN resulting in
death of 75% of the cell population. The broad caspase in-
hibitor zVAD-fmk reduced DDN-induced cell death by 50%.
To further investigate whether DDN induces apoptosis, we
also evaluated translocation of phosphatidylserine to outer
surface of the cytoplasmic membrane using annexin-FITC.
Annexin-positive cells were increased in DDN-treated cells
(Fig. 1B). DNA fragmentation characteristic of apoptosis
was evident in cells treated with 1 WM DDN for 24 h, suggest-
ing that a population of the cells underwent apoptotic cell
death (Fig. 1C).
3.2. Naphthoquinone analog induces alterations in subcellular
redistribution of cytochrome c and Bax
The release of cytochrome c from the mitochondrial inter-
membrane space into the cytosol is a prominent downstream
event of apoptotic cell death [7,8]. As shown in Fig. 2, cyto-
solic cytochrome c was increased time-dependently in DDN-
treated cells. Since Bax has been shown to induce cytochrome
c release from mitochondria to the cytosol in conjunction with
apoptosis in several cell lines and translocation of Bax to
mitochondrial outer membrane is a primary event in trigger-
ing mitochondrial function [9,11,18], we examined the subcel-
lular distribution of Bax in DDN-treated HL-60 cells. Cyto-
solic Bax was decreased and mitochondrial Bax was increased
time-dependently in accordance with increase in cytosolic
cytochrome c (Fig. 2). Bax translocation and cytochrome c
release were not inhibited by z-VAD-fmk, indicating that sub-
cellular redistribution of cytochrome c or Bax is not depen-
dent on caspase activation.
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3.3. Naphthoquinone analog induces activation of caspases
Recent evidences indicate that many chemotherapeutic
agents function proximal to the executioner caspases [20,21].
We examined whether DDN induces activation of caspase-3.
Cells treated with 1 WM of DDN resulted in a time-dependent
processing of caspase-3 (Fig. 3A). Activation of caspase by
DDN was also con¢rmed by measuring the enzyme activity
using the colorimetric substrate, Ac-DEVD-pNa. DEVDase
activity was increased in a time-dependent fashion similar to
the proteolytic processing of procaspase-3 (Fig. 3B). Clea-
vages of caspase-8 and -9 were also induced by DDN (Fig.
3A). When comparing the time course for processing of cas-
pase-3 with caspase-8 and -9, it was di⁄cult to determine
which was activated ¢rst, since caspase-8, -9 and -3 were acti-
vated with similar kinetics. Recently, it is reported that cas-
pase-8 cleaves Bid in the death receptor apoptotic pathway,
and the cleaved Bid can directly act on mitochondria to trig-
ger cytochrome c release [22]. To investigate whether caspase-
8 activation induced by DDN preceded the release of cyto-
chrome c, we examined the e¡ect of DDN on Bid cleavage
and the e¡ect of caspase inhibitor on cytochrome c release. As
shown in Fig. 3C, Bid was cleaved into a fragment of 15 kDa
in DDN-treated cells. Cleavage of Bid was inhibited by the
broad caspase inhibitor zVAD-fmk, whereas cytochrome c
release was not a¡ected by zVAD-fmk. These results indicate
that DDN-induced activation of caspase-8 and subsequent
processing of Bid occur downstream of cytochrome c release.
3.4. Akt inhibits cell death and the release of cytochrome c
induced by DDN
Akt inhibits apoptosis and the processing of procaspases in
their active forms by delaying mitochondrial changes [23]. To
further understand the mechanism by which DDN induces
cell death, we examined the e¡ect of Akt signaling on
DDN-induced apoptosis. HL-60 cells were expressed with a
constitutively active form of Akt containing the Src myristoy-
lation signal sequence, and treated with 1 WM of DDN. DDN
inhibited the activation of Akt detected by decreasing levels of
phosphorylation (Fig. 4A). Expression of MyrAkt signi¢-
cantly protected cells from DDN-induced apoptosis, whereas
expression of dominant negative Akt moderately enhanced
cell death (Fig. 4B, C). Furthermore, Akt prevented release
of cytochrome c in DDN-treated HL-60 cells. As shown in
Fig. 4D, little cytochrome c protein was detected in the cyto-
solic fraction, when active Akt was overexpressed. Recent
studies suggested that caspase-dependent cleavage of Bad
may be one of the major mechanisms in the process of apo-
ptosis in response to various apoptotic stimuli [24,25]. Bad is
a proapoptotic Bcl-2 family of proteins, and its proapoptotic
activity is regulated primarily by phosphorylation in response
Fig. 2. DDN induces subcellular redistribution of cytochrome c and
Bax. Cells were treated with 1 WM DDN for the indicated time
points, and cytosolic extracts were prepared as described in Section
2. Equal amounts of lysates were loaded, separated by SDS^PAGE
and immunoblotted with anti-Bax antibody or anti-cytochrome c
antibody.
Fig. 1. DDN induces apoptotic cell death in HL-60 cells. A: Cells
were treated with DDN at various concentrations for 24 h, and cell
viability was determined by trypan blue exclusion method. B: Apo-
ptotic cells determined by annexin staining of HL-60 cells treated
with DDN for 24 h. C: DNA fragmentation was investigated in a
dose-dependent manner. Total genomic DNA was prepared, sepa-
rated on a 1.5% agarose gel and visualized by ethidium bromide
staining.
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to survival factors [25]. Since Bad can be phosphorylated by
Akt, and inhibition of Akt prevents phosphorylation of Bad,
we examined the possible involvement of Bad in DDN-in-
duced apoptosis. No signi¢cant change in the level of phos-
pho-Bad following DDN treatment was observed (data not
shown). However, DDN treatment induced cleavage of Bad
to generate a V16-kDa cleavage product. Overexpression of
MyrAkt or treatment with zVAD-fmk blocked DDN-induced
cleavage of Bad (Fig. 5).
4. Discussion
Vitamin K-related analogs have been found to be potent
growth inhibitors of tumor cells. The growth inhibitory ac-
tions of vitamin K have been ascribed to cdc25 inhibition and
Fig. 3. Induction of caspase activity and Bid cleavage by DDN. A:
Processing of caspases by DDN. HL-60 cells were treated with 1 WM
DDN for the indicated time points. Cell lysates were prepared, and
then analyzed by immunoblotting for the processing of caspase-3,
-8, -9. B: At the indicated times, samples of cell extracts were as-
sessed for their ability to hydrolyze the peptides DEVD-pNA,
IETD-pNA and Ac-LEHD-pNA. C: Cleavage of Bid, but not cyto-
chrome c release is prevented by zVAD-fmk. HL-60 cells were
treated with 1 WM DDN in the presence or absence of zVAD-fmk
(50 WM), and then analyzed by Western blot. Results shown are
representatives of three separate experiments.
Fig. 4. Akt inhibits cell death and cytochrome c release induced by
DDN. HL-60 cells were transfected with vector, MyrAkt or domi-
nant negative Akt-K179M and treated with 1 WM DDN for 24 h.
A: Akt and phospho-Akt protein levels were analyzed by Western
blot of total cell lysates. B: Hoechst staining of cells treated with
1 WM DDN for 24 h. C: Apoptosis was measured using an ELISA
based on detection of histone-associated DNA fragments in the cy-
toplasm of apoptotic cells. HL-60 cells were treated with 1 WM
DDN for 24 h. D: Cells were treated with 1 WM DDN for 24 h,
and cytosolic and mitochondrial fractions were prepared, separated
by 15% SDS^PAGE followed by immunoblot analysis.
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cell cycle arrest [2^4]. Previously, we have reported that DDN
induces growth inhibition in various cancer cell lines and
shows antitumor activity in vivo, and presented evidence
that DDN induces apoptosis in HL-60 cells via regulating
the expression of Bcl-2 family proteins [26]. In an e¡ort to
characterize the molecular mechanisms by which DDN in-
duces apoptosis in HL-60 cells, we evaluated whether mito-
chondrial signaling is involved in the initiation of apoptosis.
Mitochondria play a major role in the apoptotic process
through the release of cytochrome c and other proapoptotic
proteins that normally reside in the intermembrane space be-
tween the inner and outer mitochondrial membrane [7,8,10]. It
is known that the release of cytochrome c from mitochondria
is an important process during apoptosis induced by chemo-
therapeutic agents, and several proapoptotic and antiapop-
totic proteins are involved the upstream and downstream of
mitochondria. Cytochrome c is released into cytosol following
the induction of apoptosis by many di¡erent stimuli including
CD95, tumor necrosis factor, and chemotherapeutic agents
[7,9,21]. In death ligand-induced apoptosis, activation of cas-
pase-8 cleaves a cytosolic substrate Bid, leading to release of
cytochrome c. Therefore, release of cytochrome c is secondary
to caspase activation. However, in irradiation or chemicals
such as staurosporine- and etoposide-induced apoptosis, cyto-
chrome c release appears to be caspase-independent as it is
not inhibited by the broad spectrum cell-permeable caspase
inhibitor, zVAD-fmk [27,28]. In this study, cytochrome c re-
lease induced by DDN was not inhibited by zVAD-fmk, but
the Bid cleavage was blocked by the caspase inhibitor. These
results suggest that Bid cleavage occurs downstream of mito-
chondrial cytochrome c release, and caspase-8 can be acti-
vated downstream of mitochondria in DDN-treated cells, sug-
gesting that the release of cytochrome c is an early event in
DDN-induced apoptosis. However, the possibility that cleav-
age of Bid through the caspase pathway independent of mi-
tochondria may not be excluded. We also demonstrated Bax
translocation from the cytosol to the mitochondria, which was
accompanied by cytochrome c release. Previous studies have
shown that ectopic expression of Bax induces mitochondria to
release cytochrome c, caspase activation, and apoptosis
[11,13]. It is also reported that Bax translocates from cyto-
plasmic location to the mitochondria upon apoptosis induc-
tion [11]. Therefore, our ¢ndings indicate that subcellular re-
distribution of Bax, which was associated with cytochrome c
release, is an important process in DDN-induced apoptosis.
Akt is known to be an important survival factor in signal
transduction pathways involved in cell growth, and considered
to be a possible target for cancer therapy [16,19,21,29]. Akt
inhibits apoptosis by inactivating proapoptotic proteins such
as Bad, procaspase-9, and forkhead and by activating anti-
apoptotic proteins such as NF-UB and cyclic adenosine mono-
phosphate (cAMP)-response element binding protein [29]. The
present data show that DDN inhibits the activation of Akt
detected by decreasing levels of phosphorylation, thereby at-
tenuating the activity of antiapoptotic pathway. Conse-
quently, overexpression of constitutively active Akt protects
cells from DDN-induced apoptosis. Akt is found to in£uence
the mitochondrial death signaling because the overexpression
of Akt caused inhibition of cytochrome c release induced by
DDN. It was shown that active Akt inhibits ultraviolet (UV)-
and etoposide-induced cytochrome c release in Rat1 ¢broblast
[23], and staurosporine-induced Bax translocation to mito-
chondria in HeLa cells [30]. These data indicate that inhibi-
tion of Akt is an important mechanism for mitochondrial
steps of death signaling induced by various apoptotic stimuli.
The molecular mechanisms by which Akt inhibits the Bax
translocation and cytochrome c release are not well under-
stood. Recent studies have shown that Bad is cleaved by a
caspase(s) during apoptosis induced by TNF-K, CD95,
TRAIL or interleukin (IL)-3 deprivation [24,25]. The trun-
cated Bad has shown higher a⁄nity for Bcl-xL, and it is a
potent inducer of cytochrome c release [24]. This implies that
deprivation of survival factors induces cleavage of Bad, result-
ing in dissociation of Bad from 14-3-3 proteins and translo-
cation to the mitochondria, where Bad interacts with Bcl-xL
and Bcl-2 and antagonizes their antiapoptotic functions [24].
In this study, we observed that DDN induced cleavage of Bad
that is inhibited by caspase inhibitor and Akt overexpression.
It is not clear whether there is a direct link between cleavage
of Bad and cytochrome c release in DDN-induced apoptosis,
because we found that cleavage of Bad by DDN was caspase-
dependent, while cytochrome c release was caspase-indepen-
dent. Therefore, it is suggested that there is an alternative
mechanism for Akt intervening cytochrome c release in
DDN-induced apoptosis.
In conclusion, DDN-induced apoptosis in HL-60 cells is
associated with mitochondrial signaling which involves trans-
Fig. 5. DDN induces cleavage of Bad. HL-60 cells were treated
with 1 WM DDN in the presence or absence of zVAD-fmk (50 WM)
for 24 h. Cell lysates were separated by SDS^PAGE and subjected
to Western blot analysis.
Fig. 6. Schematic illustration for the potential mechanisms involved
in the DDN-induced apoptotic pathway.
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location of Bax, followed by cytochrome c release (Fig. 6).
DDN induces apoptosis through the activation of caspase-3,
-9, -8 downstream of mitochondria, and through the inhibi-
tion of upstream signaling Akt, hence leading to inhibition of
survival signals, in addition to increasing death signals.
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